HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pathophysiological and clinical aspects of the insulin-like growth factors.

Abstract
Except in acromegaly, where insulin-like growth factor I (IGF I) levels are elevated, only decreased IGF levels have been observed under pathophysiological conditions. These are hypopituitarism, Laron dwarfism, leprechaunism, liver disease, primary hypothyroidism, extrapancreatic tumor hypoglycemia and severe insulin deficiency in experimental animals. For most of these diseases the diagnostic value of IGF determinations is limited. IGF I determinations may serve as a useful additional diagnostic index in acromegaly and in the evaluation of successful operative and/or radiotherapy of this disease.
AuthorsJ Zapf, E R Froesch
JournalHormone research (Horm Res) Vol. 24 Issue 2-3 Pg. 160-5 ( 1986) ISSN: 0301-0163 [Print] Switzerland
PMID3530939 (Publication Type: Journal Article, Review)
Chemical References
  • Insulin
  • Somatomedins
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
Topics
  • Acromegaly (blood, diagnosis)
  • Diabetic Retinopathy (blood)
  • Growth Disorders (blood)
  • Humans
  • Insulin (metabolism)
  • Insulin Secretion
  • Insulin-Like Growth Factor I (blood)
  • Insulin-Like Growth Factor II (blood)
  • Liver Diseases (blood)
  • Pancreas (metabolism)
  • Somatomedins (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: